ReviewArchivos de bronconeumologia2010
[Hot topics respiratory infections].
Review in Archivos de bronconeumologia, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A critical review of articles on respiratory infections published in the last three months of 2008 to the end of 2009. There are articles on patients with bronchiectasis that study their quality of life, as well as those that analyse the decrease in the number of exacerbations due to the immunomodulatory effect of using low doses of macrolides in these patients. In the diagnosis of tuberculosis, works on the application of interferon-A are especially relevant, whilst on the treatment of this disease, articles that study therapeutic innovations in the management of TB-MDR and TB-XDR or -TDR are also highlighted. As far as publications on pneumonia are concerned, there are those that analyse the progression of community acquired pneumonias (CAP) in patients affected with chronic obstructive pulmonary disease. Furthermore, special importance is given to the initial epidemiological and clinical studies of the influenza A (H1N1) pandemic. Also of interest is the evaluation of prognostic scales as predictors of ventilation support and/or the use of pressor amines, as well as the use of biological markers to complement the predictive value of these prognostic scales. Aetiological and clinical studies of pneumonias associated with the health system continue to be of great interest and their possible differences compared to CAPs. Also of interest in the treatment of the pneumonias, is the analysis of the potential inflammation modulatory ability of different drugs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.